“amitparikh.co.in”的搜索结果，显示 631-640 项，共有 5174 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the response rate to the combination of pembrolizumab and NT-I7 in patients with recurrent glioblastoma. Onvansertib ...

2. 神经科- 临床试验- 妙佑医疗国际

   The purpose of the Pediatric Proton Consortium Registry (PPCR) is to enroll children who have been treated with proton radiation in the United States in ...

3. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

5. 麻醉与围术期医学科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the hormonal profile related to opioid-induced hypogonadism (OIH) in chronic pain patients before and after ...

6. 脊髓肿瘤- 医生与科室- 妙佑医疗国际

   脊髓肿瘤会引起诸多严重问题，例如疼痛和瘫痪。了解有关管理和治疗的更多信息。

7. 心血管医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. Participants in this study will either have heart failure (HF) and are scheduled to undergo cardiac resynchronization therapy pacemaker (CRT-P) ...

8. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to assess the presence of various molecular markers in histiocytic disorders. In addition to this, to review ...

9. 血液科- 临床试验- 妙佑医疗国际

   76 研究血液科（仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 Inotuzumab Ozogamicin And Post-Induction Chemotherapy In Treating Patients With ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...